Evidence map›Paper›PMID 36539838›Full record

ArticleWorld journal of surgical oncology2022

Survival analysis and prognostic factors of the carcinoma of gallbladder.

Zainab Feroz, Priyanka Gautam, Sonia Tiwari, Girish C Shukla, Munish Kumar

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Risk Factors and Prognostic Factors in GBC.Journal of clinical medicine · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Zainab FerozDepartment of Biochemistry, University of Allahabad, Prayagraj, India.
Priyanka GautamDepartment of Biochemistry, University of Allahabad, Prayagraj, India.
Sonia TiwariDepartment of Radiation Oncology, Kamala Nehru Memorial Hospital Prayagraj, Prayagraj, India.
Girish C ShuklaDepartment of Biological Sciences, Cleveland State University, Cleveland, USA. g.shukla@csuohio.edu.
Munish KumarDepartment of Biochemistry, University of Allahabad, Prayagraj, India. munishkp@gmail.com.
University of Allahabad · INCleveland State University · USKamla Nehru Memorial Hospital · IN

Funding

Androgen signaling and sterol metabolism in metastatic prostate cancer: Functional and therapeutic implicationR15CA252997 · NCI · CLEVELAND STATE UNIVERSITY · PI SHUKLA, GIRISH C · 2021 to 2021
$412k
NCI NIH HHS R15 CA252997
6 · The paper itself

Abstract

backgroundThe present study aims to evaluate the survival status of patients with gallbladder cancer (GBC) and explore the prognostic factors for the improvement and preventions.

methodsThe study consists of 176 patients with clinically diagnosed gallbladder cancer; the study was conducted between 2019 and 2021 registered at Kamala Nehru Memorial Cancer Hospital, Prayagraj, India. The survival rates were analyzed by the Kaplan-Meier method; survival rate difference was analyzed by log-rank test, prognosis factors; and hazard ratio for mortality outcomes was estimated using Cox regression method.

resultsThe overall median survival time of patients was 5 months with the 1-year, 2-year, and 3-year survival rates of 24.4%, 8.5%, and 4.5%, respectively. The 3-year survival for patients with jaundice was 2.9%, liver infiltration (4.2%), gallstones (0.8%), and with advanced tumor grade (1.4%). Elderly GBC patients had lower survival rates (3.8%), while the 3-year overall survival for patients residing in urban areas dropped to zero. No patients in the tumor stage (T3/T4) and with distance metastasis stage survived in 3 years, while only 1.1% of patients with advanced nodal stage survived. On receiving surgery and radiation therapy, the 3-year survival rate increased to 19.5% and 35%, respectively. The results of multivariate analysis showed that urban region (HR = 1.568, p = 0.040), gallstone or not (1.571, p = 0.049), N stage (HR = 1.468, p = 0.029), and M stage (HR = 2.289, p < 0.0001) were independent risk factors for prognosis, while surgery or not (HR = 0.573, p = 0.030) was the protective factor for the prognosis of GBC.

conclusionThe overall survival of GBC in the Gangetic belt is poor. The geographical region of patients, gallstones, and N and M stage was the risk factors for prognosis, while surgery or not was the protective factor for the prognosis of GBC.

Indexed as

CarcinomaGallbladder NeoplasmsGallstonesAgedHumansNeoplasm StagingPrognosisProportional Hazards ModelsSurvival AnalysisGallbladder cancer (GBC)Overall survivalPreventionPrognosis

Identifiers

PMID36539838
PMCPMC9764491
OpenAlexW4312114958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.